Viral dsRNA inhibitors prevent self-association and autophosphorylation of PKR

Sean A McKenna1, Darrin A Lindhout, Takashi Shimoike

  • 1Department of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305-5126, USA.

Insights

Viral inhibitor RNAs, EBER(I) and VA(I), block protein kinase R (PKR) activation by preventing its dimerization. This mechanism inhibits viral replication by maintaining protein translation, crucial for host defense against viruses.

Area of Science:

  • Virology
  • Molecular Biology
  • Biochemistry

Background:

  • Host antiviral defense involves protein kinase R (PKR), a kinase activated by double-stranded RNA (dsRNA).
  • PKR phosphorylates eukaryotic initiation factor 2alpha (eIF2alpha), inhibiting protein translation and viral protein synthesis.
  • Viruses employ strategies to evade PKR, including using dsRNA inhibitors to inactivate PKR.

Purpose of the Study:

  • To investigate the mechanism by which viral dsRNA inhibitors, EBER(I) and VA(I), inhibit PKR.
  • To elucidate how these inhibitors prevent PKR activation and its downstream effects on protein translation.

Main Methods:

  • Native gel shift mobility assays to study RNA-PKR interactions.
  • Isothermal titration calorimetry to quantify binding affinities.
  • HeLa cell extract systems to assess translational recovery.

Main Results:

  • The RNA-binding domains of PKR are essential for interaction with dsRNA inhibitors.
  • EBER(I) and VA(I) inhibit PKR activation by preventing trans-autophosphorylation and dimerization.
  • dsRNA inhibitors remain bound to PKR, unlike activator dsRNAs that dissociate from phosphorylated PKR.
  • PKR inhibitors restore protein synthesis in cell extracts.

Conclusions:

  • Viral dsRNA inhibitors bind preferentially to the inactive, dephosphorylated form of PKR.
  • Inhibitors block PKR dimerization, a prerequisite for kinase activation.
  • This mechanism effectively counters viral strategies to evade host antiviral responses.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...